Benjamin D. Greenbaum

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

49h-index14.0kcitations303works6.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(65), Immunotherapy and Immune Responses(38), Cancer-related Molecular Pathways(32), Cancer Genomics and Diagnostics(27), RNA modifications and cancer(26)

Publications302 total

Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome
EBioMedicine·2025Open Access
Tumor mutational burden as a novel biomarker of resistance to CD19 CAR-T cell therapy in large B-cell lymphoma
Blood·2025
Abstract A088: Genomic Scar to Immune Signals: Translational Insights from the POLAR Trial Reveal POLQ-Driven Immunogenicity in HRD Pancreatic Cancer
Cancer Research·2025
Abstract A125: Tumor cell plasticity, stromal rewiring, and clonal T cell expansion define response and resistance to combined PARP and PD-1 blockade (POLAR) in pancreatic cancer
Cancer Research·2025
Repeats mimic pathogen-associated patterns across a vast evolutionary landscape
Cell Genomics·2025· 2 citedOpen Access
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome
iScience·2025· 1 citedOpen Access
Neoantigenic properties of <i>TP53</i> variants modify cancer risk in individuals with Li-Fraumeni syndrome
2025Open Access
Supplementary File S9 from Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
2025Open Access
Supplementary File S5 from Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
2025Open Access
Supplementary File S7 from Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
2025Open Access
Supplementary File S8 from Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
2025Open Access
Figure 4 from Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
2025Open Access
Figure 5 from Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
2025Open Access
Figure 3 from Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
2025Open Access
Supplementary Tables S1-S4 from Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
2025Open Access
Data from Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
2025Open Access
Supplementary Figures S1-S7 from Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
2025Open Access
Supplementary File S13 from Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
2025Open Access
Figure 1 from Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
2025Open Access
Supplementary File S12 from Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
2025Open Access
page 1 of 16Next →

Frequent Co-authors

Alexander Solovyov(13), Nina Bhardwaj(12), Arnold J. Levine(10), Marta Łuksza(9), Taha Merghoub(9), Jedd D. Wolchok(8), David T. Ting(8), Vinod P. Balachandran(7), David Hoyos(7), Matthew D. Hellmann(6), Zachary Sethna(5), Jayon Lihm(5), Raúl Rabadán(5), Vladimir Roudko(5), Nicolas Vabret(4), Miriam Mérad(4), Robert Samstein(4), Andrew Chow(4), Sacha Gnjatic(4), Mithat Gönen(4)